(Q28282600)

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Analgesic Abuse, Renal Papillary Necrosis and Concomitant Drug Intake

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Syndrome associated with the abuse of analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Experimental renal papillary necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Medullary Ischaemia in Experimental Analgesic Nephropathy-The Pathogenesis of Renal Papillary Necrosis*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Effect of Vasopressin on the Reabsorption of Phenacetin and its Metabolites from the Tubular Fluid in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage.: A pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Renal tubular transport of paracetamol and its conjugates in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Paracetamol metabolism by the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Effect of vasopressin on the renal tubular reabsorption and cortico-papillary concentration gradient of phenacetin and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Direct Effects of Salicylate on Renal Function in the Dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Rapid determination of salicylate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Enzyme systems involved in the formation of reactive metabolites in the renal medulla: cooxidation via prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Prostaglandin synthetase catalyzed activation of paracetamol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Mechanisms in the development of analgesic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021

Analgesic use and chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990568-5

7 January 2021